Industry Experts

Cory Schwartz is Vice President of Research and Early Development at iBio, where he leads advancement of the company’s therapeutic pipeline with a focus on obesity and related metabolic disease. His work spans the path from early antibody discovery through IND-enabling development, integrating protein engineering, translational biology, and cross-functional program leadership. He earned his PhD from the University of California, Riverside.